Literature DB >> 30372545

Nupharidine enhances Aggregatibacter actinomycetemcomitans clearance by priming neutrophils and augmenting their effector functions.

Dan Henry Levy1, Iain L C Chapple2, Lior Shapira3, Avi Golan-Goldhirsh4, Jacob Gopas1,5, David Polak3.   

Abstract

OBJECTIVES: Nupharidine (6,6'-Dihydroxythiobinupharidine), purified from the aquatic plant Nuphar lutea leaves (Water lily) prompts antimicrobial activity of immune cells. The aim of the study was to test the effect of Nupharidine on neutrophil function against Aggregatibacter actinomycetemcomitans, JP2 clone (Aa-JP2).
METHODS: Neutrophils derived from the human cell line HL60 and human peripheral blood derived from aggressive periodontitis and periodontally healthy subjects were incubated with Nupharidine or vehicle and inoculated with JP2. Bacterial survival was tested using viable counts on blood agar (CFU's). Neutrophils' necrosis/apoptosis, reactive oxygen species (ROS) production, phagocytosis and neutrophil extracellular traps (NET) production following infection were tested, as well as markers of neutrophil priming.
RESULTS: Nupharidine had no direct bactericidal effect on JP2, but it enhanced Aa-JP2 clearance by neutrophils. Nupharidine enhanced neutrophil phagocytosis, ROS production and NET formation during JP2 infection. Furthermore, Nupharidine enhanced the expression of certain markers of neutrophils priming, specifically iCAM1, DECTIN-2 and intracellular IL-1β.
CONCLUSION: Nupharidine was shown to promote neutrophil effector bactericidal functions, boosting Aa-JP2 clearance. The results point to the potential of Nupharidine as an adjunctive agent in the treatment of Aa-JP2 periodontitis, but this should be tested initially using pre-clinical and clinical studies.
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30372545     DOI: 10.1111/jcpe.13036

Source DB:  PubMed          Journal:  J Clin Periodontol        ISSN: 0303-6979            Impact factor:   8.728


  6 in total

1.  6,6'-Dihydroxythiobinupharidine as a poison of human type II topoisomerases.

Authors:  Esha D Dalvie; Jacob Gopas; Avi Golan-Goldhirsh; Neil Osheroff
Journal:  Bioorg Med Chem Lett       Date:  2019-06-04       Impact factor: 2.823

2.  Cytotoxicity of Thioalkaloid-Enriched Nuphar lutea Extract and Purified 6,6'-Dihydroxythiobinupharidine in Acute Myeloid Leukemia Cells: The Role of Oxidative Stress and Intracellular Calcium.

Authors:  Suchismita Muduli; Avi Golan-Goldhirsh; Jacob Gopas; Michael Danilenko
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-28

3.  CD18 Mediates Neutrophil Imperviousness to the Aggregatibacter actinomycetemcomitans JP2 Clone in Molar-Incisor Pattern Periodontitis.

Authors:  Koren Hashai; Ian L Chapple; Lior Shapira; Walaa Assadi; Stav Dadon; David Polak
Journal:  Front Immunol       Date:  2022-05-18       Impact factor: 8.786

Review 4.  Neutrophil Extracellular Traps in Periodontitis.

Authors:  Antonio Magán-Fernández; Sarmad Muayad Rasheed Al-Bakri; Francisco O'Valle; Cristina Benavides-Reyes; Francisco Abadía-Molina; Francisco Mesa
Journal:  Cells       Date:  2020-06-19       Impact factor: 6.600

5.  6,6'-Dihydroxythiobinupharidine (DTBN) Purified from Nuphar lutea Leaves Is an Inhibitor of Protein Kinase C Catalytic Activity.

Authors:  Kamran Waidha; Nikhil Ponnoor Anto; Divya Ram Jayaram; Avi Golan-Goldhirsh; Saravanakumar Rajendran; Etta Livneh; Jacob Gopas
Journal:  Molecules       Date:  2021-05-08       Impact factor: 4.411

6.  Nuphar lutea Extracts Exhibit Anti-Viral Activity against the Measles Virus.

Authors:  Hila Winer; Janet Ozer; Yonat Shemer; Irit Reichenstein; Brit Eilam-Frenkel; Daniel Benharroch; Avi Golan-Goldhirsh; Jacob Gopas
Journal:  Molecules       Date:  2020-04-03       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.